Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FLAT-SUGAR: Exenatide vs Prandial Insulin in T2DM
NCT01524705Phase 4Completed
- Sponsor
- University of Washington
- Start
- Aug 2012
- Primary completion
- Jul 2014
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 4 trial of exenatide in type 2 diabetes mellitus (T2DM), sponsored by University of Washington. Started Aug 2012; status: completed.
02
Drugs
exenatide
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01524705.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01524705.